Literature DB >> 11241420

CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis.

A F Ahmed1, H Ohtani, M Nio, N Funaki, S Shimaoka, H Nagura, R Ohi.   

Abstract

It is speculated that immune mechanisms are involved in bile duct damage in biliary atresia (BA), as in primary biliary cirrhosis (PBC). In BA, however, no reports have described the in situ distribution of cytotoxic T lymphocytes (CTLs) using specific markers, nor has the clinical association been clarified. The present study describes the immunohistochemical distribution of CD8+ T cells and the relevant markers [perforin, granzyme B, FasL (CD95L)] in 47 cases of BA operated upon at days 12-79. The results were compared with those of PBC. In BA, CD8+ T cells infiltrated bile ducts in a way similar to that observed in PBC. However, in sharp contrast to PBC, none of the inflammatory cells infiltrating into the bile ducts in BA expressed cytotoxic markers such as perforin, granzyme B, or Fas ligand (FasL). Clinical follow-up of patients with BA revealed that a greater degree of infiltration of bile ducts by CD8+ T cells is associated with better liver function. Taken together, these data suggest the absence of direct CTL activity against bile ducts in BA in the postnatal period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241420     DOI: 10.1002/1096-9896(2000)9999:9999<::aid-path793>3.0.co;2-o

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype.

Authors:  Jun Li; Kazuhiko Bessho; Pranavkumar Shivakumar; Reena Mourya; Sujit Kumar Mohanty; Jorge L Dos Santos; Irene K Miura; Gilda Porta; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 2.  Biliary atresia: will blocking inflammation tame the disease?

Authors:  Kazuhiko Bessho; Jorge A Bezerra
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 3.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

Review 4.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 5.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

Review 6.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 7.  Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models.

Authors:  Yoshiyuki Ueno; Yuki Moritoki; Tooru Shimosegawa; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

8.  Association of interferon-gamma gene polymorphisms in Taiwanese children with biliary atresia.

Authors:  Hung-Chang Lee; Tzu-Yang Chang; Chun-Yan Yeung; Wai-Tao Chan; Chuen-Bin Jiang; Wei-Fang Chen; Hui-Wen Chan; Hsin-Fu Liu; Marie Lin; Yann-Jinn Lee
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

9.  Polymorphisms of the ICAM-1 gene are associated with biliary atresia.

Authors:  Cigdem Arikan; Afig Berdeli; Murat Kilic; Gokhan Tumgor; Rasit V Yagci; Sema Aydogdu
Journal:  Dig Dis Sci       Date:  2008-04-10       Impact factor: 3.199

Review 10.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.